Skip to main content
Smart Investors Daily
Invesco Nasdaq Biotechnology ETF logo

NYSE · IBBQ

Invesco Nasdaq Biotechnology ETF

Financial Services · Asset Management

$33.72

Down-$0.94 (-2.73%)

Updated Oct 18, 2026, 11:01 PM

SID Score

4.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
41.2M
P/E ratio
—
Dividend yield
0.67%
52-week range
$27.46 – $36.84
Volume
17.88K
Avg. volume
20K

Price performance · IBBQ

IBBQ price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 16, 2026

IBBQ closed at $33.72 after 20 trading sessions, down 3.25% for the selected period.

Last close
$33.72
Period change
-3.25%
Period low
$33.43
Period high
$35.40
Daily close
View OHLC price history
IBBQ OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 16, 2026$34.85$34.85$33.67$33.715417.88K
Oct 15, 2026$34.31$34.8796$34.23$34.6629.69K
Oct 14, 2026$33.38$34.05$33.38$33.9341.28K
Oct 13, 2026$34.02$34.02$33.4334$33.433446.7K
Oct 12, 2026$34.66$34.69$34.23$34.248221.19K
Oct 9, 2026$33.80$34.68$33.7079$34.6231.48K
Oct 8, 2026$33.75$33.75$33.03$33.624928.32K
Oct 7, 2026$33.78$34.39$33.63$34.01103.66K
Oct 6, 2026$34.94$34.94$33.659$33.9033.14K
Oct 5, 2026$34.53$34.80$34.07$34.75100.22K
Oct 2, 2026$34.78$34.78$34.20$34.37134.91K
Oct 1, 2026$35.18$35.2874$34.42$34.4267.42K
Sep 30, 2026$35.255$35.50$35.11$35.1426.32K
Sep 29, 2026$35.36$35.47$34.83$35.24124.33K
Sep 28, 2026$34.95$35.39$34.59$35.2827.15K
Sep 25, 2026$35.20$35.20$34.755$35.0034.44K
Sep 24, 2026$34.52$35.03$34.49$34.9744.75K
Sep 23, 2026$35.50$35.53$34.56$34.7639.88K
Sep 22, 2026$35.05$35.58$34.865$35.4051.95K
Sep 21, 2026$34.59$34.9984$34.485$34.849537.96K

Latest IBBQ news

The latest Smart Investors Daily articles mentioning IBBQ.

IBBQ research

Overview

Company profile and research snapshot.

Company profile

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.